Advanced Solid Tumour Clinical Trials

3 recruiting

About Advanced Solid Tumour Clinical Trials

Looking for clinical trials for Advanced Solid Tumour? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Advanced Solid Tumour trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Advanced Solid Tumour clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd140 enrolled6 locationsNCT07111546
Recruiting
Phase 2

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd110 enrolled7 locationsNCT07331155
Recruiting
Phase 1Phase 2

Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

Advanced Solid Tumours
Pyxis Oncology, Inc220 enrolled15 locationsNCT06795412
Recruiting
Phase 1

First in Human Study of AZD9592 in Solid Tumors

Advanced Solid Tumours
AstraZeneca403 enrolled50 locationsNCT05647122
Recruiting
Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd230 enrolled24 locationsNCT06783647
Recruiting
Phase 1

A Study of EBC-129 in Advanced Solid Tumours

Advanced Solid Tumours
EDDC (Experimental Drug Development Centre), A*STAR Research Entities98 enrolled5 locationsNCT05701527
Recruiting
Phase 1

First in Human Study of SIM0610 in Solid Tumors

Advanced Solid Tumours
Jiangsu Simcere Pharmaceutical Co., Ltd.260 enrolled7 locationsNCT07348211
Recruiting
Phase 1

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Advanced Solid TumoursSolid Tumours
Race Oncology Ltd53 enrolled5 locationsNCT06815575
Recruiting
Phase 1Phase 2

A Study of LM-168 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Advanced Solid Tumours
LaNova Medicines Limited87 enrolled6 locationsNCT06868199
Recruiting
Phase 1

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.

Advanced Solid Tumours
Shandong Boan Biotechnology Co., Ltd70 enrolled1 locationNCT06927349
Recruiting
Phase 1

Human Epidermal Growth Factor Receptor 2 (HER2) Antibody Therapy with Lutetium-177 in Patients with Advanced Solid Tumours.

Advanced Solid Tumours
Radiopharm Theranostics Ltd24 enrolled4 locationsACTRN12625000191493
Recruiting
Phase 1Phase 2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Squamous Cell Carcinoma of Head and NeckAdvanced Solid Tumours
Cancer Research UK167 enrolled2 locationsNCT06380816
Recruiting
Phase 1Phase 2

A Study of RC88 Combined With Sintilimab for Advanced Solid Tumours

Advanced Solid Tumours
RemeGen Co., Ltd.82 enrolled1 locationNCT05804526
Recruiting
Phase 1

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacology, and Preliminary Efficacy of AT-0174 in Subjects with Advanced Solid Malignancies

Locally Advanced Solid Tumours
Antido Therapeutics (Australia) Pty Ltd33 enrolled5 locationsACTRN12623000956606
Recruiting
Phase 1

A Phase I study of 4-(N-(S-penicillaminylacetyl)amino) phenylarsonous acid (PENAO) given as a continuous intravenous infusion, to patients with advanced solid tumours

Patients with advanced solid tumours
University of NSW35 enrolled1 locationACTRN12612000908831